Skip to content

ATTO

Attovia Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$25.55
+5.58%
Ask drillr
21
Insider buys (3m)
40
Insider sells (3m)
$47.9M
Net value (3m)
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Aug 28, 2026WALSH COLIN · directorPurchase2,872$0.00
Aug 28, 2026WALSH COLIN · directorPurchase45,588$0.00
Aug 28, 2026GOLDMAN SACHS GROUP INC · other: Former 10% OwnerPurchase5,744$0.00
Aug 28, 2026GOLDMAN SACHS GROUP INC · other: Former 10% OwnerPurchase11,398$0.00
Aug 28, 2026GOLDMAN SACHS GROUP INC · other: Former 10% OwnerPurchase45,588$0.00
Aug 28, 2026GOLDMAN SACHS GROUP INC · other: Former 10% OwnerPurchase11,488$0.00
Aug 28, 2026GOLDMAN SACHS GROUP INC · other: Former 10% OwnerPurchase28,717$0.00
Aug 28, 2026GOLDMAN SACHS GROUP INC · other: Former 10% OwnerPurchase2,872$0.00
Aug 28, 2026WALSH COLIN · directorPurchase11,398$0.00
Aug 28, 2026WALSH COLIN · directorPurchase11,488$0.00
Aug 28, 2026WALSH COLIN · directorPurchase5,744$0.00
Aug 28, 2026WALSH COLIN · directorPurchase28,717$0.00
Aug 13, 2026WALSH COLIN · directorSale672$22
Aug 13, 2026WALSH COLIN · directorSale6,970$22
Aug 13, 2026WALSH COLIN · directorSale400$22
Aug 13, 2026WALSH COLIN · directorSale1,180$22
Aug 13, 2026WALSH COLIN · directorSale300$21
Aug 13, 2026WALSH COLIN · directorSale443$22
Aug 13, 2026WALSH COLIN · directorSale700$22
Aug 13, 2026WALSH COLIN · directorSale1,163$22
Aug 13, 2026WALSH COLIN · directorSale6,763$22
Aug 13, 2026WALSH COLIN · directorSale76,418$21
Aug 13, 2026WALSH COLIN · directorPurchase500,000$17
Aug 13, 2026GOLDMAN SACHS GROUP INC · other: Former 10% OwnerPurchase85,000$21
Aug 13, 2026GOLDMAN SACHS GROUP INC · other: Former 10% OwnerSale988$22
Aug 13, 2026GOLDMAN SACHS GROUP INC · other: Former 10% OwnerSale447$22
Aug 13, 2026GOLDMAN SACHS GROUP INC · other: Former 10% OwnerSale1,332$22
Aug 13, 2026GOLDMAN SACHS GROUP INC · other: Former 10% OwnerSale200$22
Aug 13, 2026GOLDMAN SACHS GROUP INC · other: Former 10% OwnerSale1,556$22
Aug 13, 2026GOLDMAN SACHS GROUP INC · other: Former 10% OwnerSale3,402$22

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 28, 2026